Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer’s disease (original) (raw)

References

1. Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766
   CAS PubMed Google Scholar
2. Esler WP, Wolfe MS (2001) A portrait of Alzheimer secretases-new features and familiar faces. Science 293:1449–1454
   Article CAS PubMed Google Scholar
3. LeVine H, 3rd (1993) Thioflavine T interaction with synthetic Alzheimer’s disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2:404–410
   CAS PubMed Google Scholar
4. Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298:789–791
   Article CAS PubMed Google Scholar
5. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D et al. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15:1203–1218
   Article CAS PubMed Google Scholar
6. Nicolau C, Greferath R, Balaban TS, Lazarte JE, Hopkins RJ (2002) A liposome-based therapeutic vaccine against beta-amyloid plaques on the pancreas of transgenic NORBA mice. Proc Natl Acad Sci U S A 99:2332–2337
   Article CAS PubMed Google Scholar
7. Mohajeri MH, Saini K, Schultz JG, Wollmer MA, Hock C, Nitsch RM (2002) Passive immunization against beta-amyloid peptide protects CNS neurons from increased vulnerability associated with an Alzheimer’s disease-causing mutation. J Biol Chem 14:14
   Google Scholar
8. Dodart JC, Bales KR, Paul SM (2003) Immunotherapy for Alzheimer’s disease: will vaccination work? Trends Mol Med 9:85–87
   Article PubMed Google Scholar
9. Monsonego A, Weiner HL (2003) Immunotherapeutic approaches to Alzheimer’s disease. Science 302:834–838
   Article CAS PubMed Google Scholar
10. Frenkel D, Katz O, Solomon B (2000) Immunization against Alzheimer’s beta-amyloid plaques via EFRH phage administration. Proc Natl Acad Sci USA 97:11455–11459
    Article CAS PubMed Google Scholar
11. Town T, Tan J, Sansone N, Obregon D, Klein T, Mullan M (2001) Characterization of murine immunoglobulin G antibodies against human amyloid-beta1–42. Neurosci Lett 307:101–104
    Article CAS PubMed Google Scholar
12. Solomon B, Koppel R, Frankel D, Hanan-Aharon E (1997) Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci USA 94:4109–4112
    Article CAS PubMed Google Scholar
13. O’Nuallain B, Wetzel R (2002) Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci USA 99:1485–1490
    Article CAS PubMed Google Scholar
14. DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 98:8850–8855
    Article CAS PubMed Google Scholar
15. DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer’s disease. Science 295:2264–2267
    Article CAS PubMed Google Scholar
16. Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM, Paul SM (2002) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer’s disease model. Nat Neurosci 8:8
    Google Scholar
17. Solomon B, Koppel R, Hanan E, Katzav T (1996) Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proc Natl Acad Sci USA 93:452–455
    Article CAS PubMed Google Scholar
18. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916–919
    Article CAS PubMed Google Scholar
19. Pirttila T, Kim KS, Mehta PD, Frey H, Wisniewski HM (1994) Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer’s disease, vascular dementia and controls. J Neurol Sci 127:90–95
    Article CAS PubMed Google Scholar
20. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173–177
    Article CAS PubMed Google Scholar
21. Spooner ET, Desai RV, Mori C, Leverone JF, Lemere CA (2002) The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol. Vaccine 21:290–297
    Article CAS PubMed Google Scholar
22. Check E (2002) Nerve inflammation halts trial for Alzheimer’s drug. Nature 415:462
    Article CAS Google Scholar
23. Wolchok JD, Gregor PD, Nordquist LT, Slovin SF, Scher HI (2003) DNA vaccines: an active immunization strategy for prostate cancer. Semin Oncol 30:659–666
    CAS PubMed Google Scholar
24. Ramshaw IA, Ramsay AJ (2000) The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 21:163–165
    Article CAS PubMed Google Scholar
25. Schultz J, Dollenmaier G, Molling K (2000) Update on antiviral DNA vaccine research (1998–2000). Intervirology 43:197–217
    Article CAS PubMed Google Scholar
26. Robinson HL, Montefiori DC, Johnson RP, Kalish ML, Lydy SL, McClure HM (2000) DNA priming and recombinant pox virus boosters for an AIDS vaccine. Dev Biol 104:93–100
    CAS Google Scholar
27. McCluskie MJ, Brazolot Millan CL, Gramzinski RA, Robinson HL, Santoro JC, Fuller JT, Widera G, Haynes JR, Purcell RH, Davis HL (1999) Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 5:287–300
    Article CAS PubMed Google Scholar
28. Montgomery DL, Shiver JW, Leander KR, Perry HC, Friedman A, Martinez D, Ulmer JB, Donnelly JJ, Liu MA (1993) Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol 12:777–783
    CAS PubMed Google Scholar
29. Schultz J, Pavlovic J, Strack B, Nawrath M, Moelling K (1999) Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA. Hum Gene Ther 10:407–417
    Article CAS PubMed Google Scholar
30. Chen CA, Okayama H (1988) Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6:632–638
    CAS PubMed Google Scholar
31. Hock C, Konietzko U, Papassotiropoulos A, Wollmer A, Streffer J, Von Rotz RC, Davey G, Moritz E, Nitsch RM (2002) Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat Med 8:1270–1275
    Article CAS PubMed Google Scholar
32. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497
    CAS PubMed Google Scholar
33. Wenschuh H, Volkmer-Engert R, Schmidt M, Schulz M, Schneider-Mergener J, Reineke U (2000) Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. Biopolymers 55:188–206
    Article CAS PubMed Google Scholar
34. Kramer A, Volkmer-Engert R, Malin R, Reineke U, Schneider-Mergener J (1993) Simultaneous synthesis of peptide libraries on single resin and continuous cellulose membrane supports: examples for the identification of protein, metal and DNA binding peptide mixtures. Pept Res 6:314–319
    CAS PubMed Google Scholar
35. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546–549
    Article CAS PubMed Google Scholar
36. Moelling K (2000) Viral DNA Vaccines. Intervirology 43:2–10
    Google Scholar
37. Weber R, Bossart W, Cone R, Luethy R, Moelling K (2001) Phase I clinical trial with HIV-1 gp160 plasmid vaccine in HIV-1-infected asymptomatic subjects. Eur J Clin Microbiol Infect Dis 20:800–803
    Article CAS PubMed Google Scholar
38. Schenk D (2002) Opinion: amyloid-beta immunotherapy for Alzheimer’s disease: the end of the beginning. Nat Rev Neurosci 3:824–828
    Article CAS PubMed Google Scholar
39. Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412:739–743
    Article CAS PubMed Google Scholar
40. Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M (2002) Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298:1379
    Article CAS PubMed Google Scholar

Download references